MicroPort Scientific Corporation (HKG: 0853)
Hong Kong
· Delayed Price · Currency is HKD
5.63
-0.31 (-5.22%)
Jan 3, 2025, 4:08 PM HKT
MicroPort Scientific Revenue
MicroPort Scientific had revenue of $558.70M USD in the half year ending June 30, 2024, with 37.96% growth. This brings the company's revenue in the last twelve months to $1.03B, up 11.80% year-over-year. In the year 2023, MicroPort Scientific had annual revenue of $950.73M with 13.07% growth.
Revenue (ttm)
$1.03B
Revenue Growth
+11.80%
P/S Ratio
1.28
Revenue / Employee
$124.77K
Employees
8,230
Market Cap
10.40B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 950.73M | 109.89M | 13.07% |
Dec 31, 2022 | 840.83M | 62.19M | 7.99% |
Dec 31, 2021 | 778.64M | 129.91M | 20.02% |
Dec 31, 2020 | 648.73M | -144.76M | -18.24% |
Dec 31, 2019 | 793.49M | 124.00M | 18.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Innovent Biologics | 8.01B |
Sino Biopharmaceutical | 29.86B |
CSPC Pharmaceutical Group | 33.53B |
MicroPort Scientific News
- 2 months ago - Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific - BNN Bloomberg